• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

症状性重度主动脉瓣狭窄患者的终身管理:计算机断层扫描模拟研究。

Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study.

机构信息

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.

Department of Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.

出版信息

EuroIntervention. 2022 Aug 5;18(5):e407-e416. doi: 10.4244/EIJ-D-21-01091.

DOI:10.4244/EIJ-D-21-01091
PMID:35321859
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10259244/
Abstract

BACKGROUND

Given enough time, transcatheter heart valves (THVs) will degenerate and may require reintervention. Redo transcatheter aortic valve implantation (TAVI) is an attractive strategy but carries a risk of coronary obstruction.

AIMS

We sought to predict how many TAVIs patients could undergo in their lifetime using computed tomography (CT) simulation.

METHODS

We analysed paired CT scans (baseline and 30 days post-TAVI) from patients in the LRT trial and EPROMPT registry. We implanted virtual THVs on baseline CTs, comparing predicted valve-to-coronary (VTC) distances to 30-day CT VTC distances to evaluate the accuracy of CT simulation. We then simulated implantation of a second virtual THV within the first to estimate the risk of coronary obstruction due to sinus sequestration and the need for leaflet modification.

RESULTS

We included 213 patients with evaluable paired CTs. There was good agreement between virtual (baseline) and actual (30 days) CT measurements. CT simulation of TAVI followed by redo TAVI predicted low coronary obstruction risk in 25.4% of patients and high risk, likely necessitating leaflet modification, in 27.7%, regardless of THV type. The remaining 46.9% could undergo redo TAVI so long as the first THV was balloon-expandable but would likely require leaflet modification if the first THV was self-expanding.

CONCLUSIONS

Using cardiac CT simulation, it is possible to predict whether a patient can undergo multiple TAVI procedures in their lifetime. Those who cannot may prefer to undergo surgery first. CT simulation could provide a personalised lifetime management strategy for younger patients with symptomatic severe aortic stenosis and inform decision-making.

CLINICALTRIALS

gov: NCT02628899; ClinicalTrials.gov: NCT03557242; ClinicalTrials.gov: NCT03423459.

摘要

背景

经导管心脏瓣膜(THV)会随着时间的推移而退化,可能需要再次介入。再次行经导管主动脉瓣植入术(TAVI)是一种有吸引力的策略,但存在冠状动脉阻塞的风险。

目的

我们试图通过计算机断层扫描(CT)模拟预测患者一生中可以进行多少次 TAVI。

方法

我们分析了 LRT 试验和 EPROMPT 注册中心的患者配对 CT 扫描(基线和 TAVI 后 30 天)。我们在基线 CT 上植入虚拟 THV,将预测的瓣膜-冠状动脉(VTC)距离与 30 天 CT VTC 距离进行比较,以评估 CT 模拟的准确性。然后,我们模拟植入第二个虚拟 THV,以估计窦隔离和需要瓣叶修改导致冠状动脉阻塞的风险。

结果

我们纳入了 213 例可评估配对 CT 的患者。虚拟(基线)和实际(30 天)CT 测量之间存在良好的一致性。TAVI 后 CT 模拟随后进行 redo TAVI 预测 25.4%的患者冠状动脉阻塞风险低,27.7%的患者风险高,可能需要瓣叶修改,而不管 THV 类型如何。其余 46.9%的患者可以进行 redo TAVI,但前提是第一个 THV 是球囊扩张的,但如果第一个 THV 是自扩张的,可能需要瓣叶修改。

结论

使用心脏 CT 模拟,可以预测患者一生中是否可以进行多次 TAVI 手术。那些不能进行 TAVI 手术的患者可能更愿意先进行手术。CT 模拟可以为有症状的严重主动脉瓣狭窄的年轻患者提供个性化的终生管理策略,并为决策提供信息。

临床试验

gov:NCT02628899;ClinicalTrials.gov:NCT03557242;ClinicalTrials.gov:NCT03423459。

相似文献

1
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study.症状性重度主动脉瓣狭窄患者的终身管理:计算机断层扫描模拟研究。
EuroIntervention. 2022 Aug 5;18(5):e407-e416. doi: 10.4244/EIJ-D-21-01091.
2
Risk of Coronary Obstruction and Feasibility of Coronary Access After Repeat Transcatheter Aortic Valve Replacement With the Self-Expanding Evolut Valve: A Computed Tomography Simulation Study.经皮主动脉瓣置换术后重复使用自膨式 Evolut 瓣膜的冠状动脉阻塞风险和冠状动脉入路的可行性:计算机断层扫描模拟研究。
Circ Cardiovasc Interv. 2020 Dec;13(12):e009496. doi: 10.1161/CIRCINTERVENTIONS.120.009496. Epub 2020 Dec 4.
3
Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients.低危人群行 TAVR 患者的冠状动脉入路和主动脉瓣再介入的可行性。
JACC Cardiovasc Interv. 2020 Mar 23;13(6):726-735. doi: 10.1016/j.jcin.2020.01.202.
4
Risk Assessment of Coronary Obstruction During Transcatheter Aortic Valve Replacement: Insights From Post-BASILICA Computed Tomography.经 BASILICA 后 CT 扫描评估经导管主动脉瓣置换术期间的冠状动脉阻塞风险
JACC Cardiovasc Interv. 2022 Mar 14;15(5):496-507. doi: 10.1016/j.jcin.2022.01.003.
5
Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial.经皮球囊扩张式与自膨式主动脉瓣置换术后 2 年的临床疗效:GALILEO 试验的亚组分析。
Catheter Cardiovasc Interv. 2022 Oct;100(4):636-645. doi: 10.1002/ccd.30370. Epub 2022 Aug 30.
6
Redo-Transcatheter Aortic Valve Implantation Using the SAPIEN 3/Ultra Transcatheter Heart Valves-Expert Consensus on Procedural Planning and Techniques.经导管主动脉瓣置换术使用 SAPIEN 3/Ultra 经导管心脏瓣膜-专家对手术规划和技术的共识。
Am J Cardiol. 2023 Apr 1;192:228-244. doi: 10.1016/j.amjcard.2023.01.010. Epub 2023 Jan 27.
7
Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy.自膨式 Evolut 瓣膜再次经导管主动脉瓣置换术的可行性:来自 Evolut 低危试验亚组研究的 CT 分析。
EuroIntervention. 2023 Jul 17;19(4):e330-e339. doi: 10.4244/EIJ-D-22-01125.
8
Redo-TAVI with SAPIEN 3 in SAPIEN XT or SAPIEN 3 - impact of pre- and post-dilatation on final THV expansion.SAPIEN 3 在 SAPIEN XT 或 SAPIEN 3 中的经导管主动脉瓣置换术(TAVI)-预扩张和后扩张对最终 THV 扩张的影响。
EuroIntervention. 2023 Nov 17;19(9):757-765. doi: 10.4244/EIJ-D-23-00308.
9
Redo Transcatheter Aortic Valve Implantation in the Lotus Mechanically Expanded Transcatheter Heart Valve: Bench-Top Analysis, Clinical Experience, and Procedural Guidance.经皮球囊扩张式 Lotus 经导管主动脉瓣置换术治疗失败后再次行经导管主动脉瓣置换术:基于体外分析、临床经验及操作指导
Circ Cardiovasc Interv. 2023 Nov;16(11):e013296. doi: 10.1161/CIRCINTERVENTIONS.123.013296. Epub 2023 Nov 21.
10
Impact of left ventricular outflow tract calcium on valve geometry in self-expanding transcatheter aortic-valve replacement.左心室流出道钙对自膨式经导管主动脉瓣置换术中瓣膜几何结构的影响。
Catheter Cardiovasc Interv. 2022 Sep;100(3):404-412. doi: 10.1002/ccd.30301. Epub 2022 Jun 20.

引用本文的文献

1
Transcatheter Aortic Valve Implantation Indications and Patient Selection.经导管主动脉瓣植入术的适应症及患者选择
Interv Cardiol. 2025 Jun 10;20:e19. doi: 10.15420/icr.2024.44. eCollection 2025.
2
Redo-Transcatheter Aortic Valve Replacement Procedural Optimization and Patient Selection: From Bench to Clinical Practice.再次经导管主动脉瓣置换术的手术优化与患者选择:从实验台到临床实践
J Clin Med. 2025 Apr 17;14(8):2770. doi: 10.3390/jcm14082770.
3
Lifetime management considerations to optimise transcatheter aortic valve implantation: a practical guide.优化经导管主动脉瓣植入术的终生管理考量:实用指南。
EuroIntervention. 2024 Dec 16;20(24):e1493-e1504. doi: 10.4244/EIJ-D-24-00332.
4
Visualization of transcatheter aortic valve implantation from the perspective of bibliometric analysis.从文献计量学分析角度看经导管主动脉瓣植入术的可视化
Heliyon. 2024 Jun 14;10(12):e33061. doi: 10.1016/j.heliyon.2024.e33061. eCollection 2024 Jun 30.
5
Impact of leaflet splitting on coronary access after redo-TAVI for degenerated supra-annular self-expanding platforms.瓣叶切开术对退行性瓣上自膨式支架再次经导管主动脉瓣置换术后冠状动脉入路的影响。
EuroIntervention. 2024 Jun 17;20(12):e770-e780. doi: 10.4244/EIJ-D-24-00107.
6
Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study.经 Evolut 失败的再次 TAVR 后行冠状动脉入路的可行性:一项计算机断层扫描模拟研究。
Circ Cardiovasc Interv. 2023 Nov;16(11):e013238. doi: 10.1161/CIRCINTERVENTIONS.123.013238. Epub 2023 Nov 21.
7
TAVR in TAVR: Where Are We in 2023 for Management of Failed TAVR Valves?经导管主动脉瓣置换术(TAVR)中失败的 TAVR 瓣膜的处理:2023 年我们处于什么位置?
Curr Cardiol Rep. 2023 Nov;25(11):1425-1431. doi: 10.1007/s11886-023-01959-7. Epub 2023 Oct 10.
8
Coronary Obstruction during Valve-in-Valve Transcatheter Aortic Valve Replacement: Pre-Procedural Risk Evaluation, Intra-Procedural Monitoring, and Follow-Up.经导管主动脉瓣置换术(瓣中瓣技术)中的冠状动脉阻塞:术前风险评估、术中监测及随访
J Cardiovasc Dev Dis. 2023 Apr 23;10(5):187. doi: 10.3390/jcdd10050187.
9
Transcatheter heart valve commissural alignment: an updated review.经导管心脏瓣膜连合对齐:最新综述
Front Cardiovasc Med. 2023 Apr 19;10:1154556. doi: 10.3389/fcvm.2023.1154556. eCollection 2023.
10
Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy.自膨式 Evolut 瓣膜再次经导管主动脉瓣置换术的可行性:来自 Evolut 低危试验亚组研究的 CT 分析。
EuroIntervention. 2023 Jul 17;19(4):e330-e339. doi: 10.4244/EIJ-D-22-01125.

本文引用的文献

1
Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement.低手术风险主动脉瓣狭窄患者经导管主动脉瓣置换术与外科主动脉瓣置换术随机分组的 8 年结果。
Eur Heart J. 2021 Aug 7;42(30):2912-2919. doi: 10.1093/eurheartj/ehab375.
2
Incidence, Causes, and Outcomes Associated With Urgent Implantation of a Supplementary Valve During Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术中紧急植入辅助瓣膜的发生率、原因和结局。
JAMA Cardiol. 2021 Aug 1;6(8):936-944. doi: 10.1001/jamacardio.2021.1145.
3
Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement: Results From the Multicenter International BASILICA Registry.经导管主动脉瓣置换术中预防冠状动脉阻塞:多中心国际 BASILICA 注册研究结果。
JACC Cardiovasc Interv. 2021 May 10;14(9):941-948. doi: 10.1016/j.jcin.2021.02.035. Epub 2021 Mar 6.
4
Surgical Explantation of Transcatheter Aortic Bioprostheses: Balloon vs Self-Expandable Devices.经导管主动脉生物瓣的外科取出:球囊扩张型与自膨型装置。
Ann Thorac Surg. 2022 Jan;113(1):138-145. doi: 10.1016/j.athoracsur.2021.01.041. Epub 2021 Feb 3.
5
Randomized Trial of Aspirin Versus Warfarin After Transcatheter Aortic Valve Replacement in Low-Risk Patients.经导管主动脉瓣置换术后低危患者中阿司匹林与华法林的随机对照试验。
Circ Cardiovasc Interv. 2021 Jan;14(1):e009983. doi: 10.1161/CIRCINTERVENTIONS.120.009983. Epub 2021 Jan 11.
6
Balloon-Assisted BASILICA to Facilitate Redo TAVR.球囊辅助BASILICA技术助力经导管主动脉瓣置换术再次手术
JACC Cardiovasc Interv. 2021 Mar 8;14(5):578-580. doi: 10.1016/j.jcin.2020.10.056. Epub 2021 Jan 19.
7
Risk of Coronary Obstruction and Feasibility of Coronary Access After Repeat Transcatheter Aortic Valve Replacement With the Self-Expanding Evolut Valve: A Computed Tomography Simulation Study.经皮主动脉瓣置换术后重复使用自膨式 Evolut 瓣膜的冠状动脉阻塞风险和冠状动脉入路的可行性:计算机断层扫描模拟研究。
Circ Cardiovasc Interv. 2020 Dec;13(12):e009496. doi: 10.1161/CIRCINTERVENTIONS.120.009496. Epub 2020 Dec 4.
8
Risk of Coronary Obstruction Due to Sinus Sequestration in Redo Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后窦房隔离致冠状动脉阻塞的风险。
JACC Cardiovasc Interv. 2020 Nov 23;13(22):2617-2627. doi: 10.1016/j.jcin.2020.09.022.
9
Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed Tomography.经多排螺旋计算机断层扫描评估的 TAVR 内再 TAVR 后的冠状动脉入路
JACC Cardiovasc Interv. 2020 Nov 9;13(21):2528-2538. doi: 10.1016/j.jcin.2020.06.016.
10
Incidence, Characteristics, Predictors, and Outcomes of Surgical Explantation After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后外科取出的发生率、特征、预测因素和结局。
J Am Coll Cardiol. 2020 Oct 20;76(16):1848-1859. doi: 10.1016/j.jacc.2020.08.048.